Beneficient (NASDAQ:BENF – Get Free Report) Director Peter Cangany, Jr. bought 18,868 shares of the stock in a transaction on Tuesday, September 15th. The stock was purchased at an average cost of $1.06 per share, for a total transaction of $20,000.08. Following the acquisition, the director owned 98,529 shares of the company’s stock, valued at $104,440.74. This trade represents a 23.69% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
Beneficient Stock Performance
Shares of NASDAQ:BENF opened at $0.56 on Friday. The stock’s 50-day simple moving average is $2.43 and its two-hundred day simple moving average is $3.15. The stock has a market capitalization of $8.16 million, a price-to-earnings ratio of -0.08 and a beta of -0.04. Beneficient has a 52-week low of $0.54 and a 52-week high of $12.48.
Beneficient (NASDAQ:BENF – Get Free Report) last released its quarterly earnings results on Friday, August 14th. The company reported ($0.47) EPS for the quarter, beating the consensus estimate of ($2.06) by $1.59. The business had revenue of $15.93 million for the quarter, compared to analysts’ expectations of $10.16 million. As a group, equities analysts forecast that Beneficient will post -9.5 earnings per share for the current fiscal year.
Analysts Set New Price Targets
Get Our Latest Analysis on BENF
About Beneficient
Beneficient is a financial services company that provides liquidity solutions for holders of alternative assets. Its platform is designed to help investors access cash from otherwise illiquid investments, including interests in private equity, private credit, venture capital, real estate and other privately held assets.
The company offers trust-based liquidity and wealth-management solutions intended to simplify the process of monetizing alternative investments. Beneficient also provides related administrative, custody and fiduciary services through its technology-enabled platform, serving individual investors, trusts and other eligible asset holders.
Beneficient is headquartered in Dallas, Texas.
See Also
- Five stocks we like better than Beneficient
- J.B. Hunt’s Stock Plunges After Market Misprices Profit Warning
- 2 Stocks Breaking Out Post-FOMC With One Thing in Common
- Lennar’s Q3 Miss Hides a Stronger Operating Story Beneath the Housing Slump
- These 3 Stocks Are Drawing Insider Buyers for Very Different Reasons
Receive News & Ratings for Beneficient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beneficient and related companies with MarketBeat.com's FREE daily email newsletter.
